Sort
50,496 grants matching “lung cancer”
Comparative Biomedical Scientist Training Program
$905,452Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2013 · CA
Identifying non-coding RNAs for early detection and prevention of lung cancer
$905,221Carlo M Croce · Ohio State University · U01 · FY2015 · CA
Senescence-on-a-chip: Building a microphysiological 3D skin model
$904,750Angela M Christiano · Columbia University Health Sciences · UH3 · FY2024 · CA
Senescence-on-a-chip: Building a microphysiological 3D skin model
$904,750Angela M Christiano · Columbia University Health Sciences · UH3 · FY2025 · CA
Regulation of Ras-Dependent Signal Transduction Pathways
$904,415Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
$904,402Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · R35 · FY2017 · CA
Impact of Hearing Loss and Tinnitus in Cancer Survivors
$904,351Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2017 · CA
Hematopathology Diagnosis
$904,289Elaine Jaffe · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
$904,242Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · R35 · FY2018 · CA
Clinical Protocol and Data Management (Core 012)
$903,736Dan Toby Vogl · University Of Pennsylvania · P30 · FY2019 · CA
Human metabolic variation as a window into cancer initiation and progression
$903,713Ralph J Deberardinis · Ut Southwestern Medical Center · R35 · FY2024 · CA
Molecular Diagnostics Core Laboratory
$903,497Liqiang Xi · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Biostatistic
$903,482Mithat Gonen · Sloan-Kettering Inst Can Research · P30 · FY2017 · CA
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.
$903,043Gary Matthew Hunninghake · Brigham And Women'S Hospital · R01 · FY2019 · HL
Cancer Immunotherapy Clinical Trials
$902,872Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
(3 of 3) MMC, VICC & TSU: Partners in Eliminating Cancer Disparities
$902,465Margaret M Whalen · Tennessee State University · U54 · FY2025 · CA
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
$901,735Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · R35 · FY2022 · CA
Development of a radiation-activatable nanoparticle for lung cancer therapy
$901,390Jin Xie · Athna Biotech, Inc. · R42 · FY2025 · CA
Lung Cancer Health Disparities
$901,339Brid Ryan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy
$901,309Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2022 · CA
Immunobiology of Lung Injury and Fibrosis
$901,281Bethany B. Moore · University Of Michigan At Ann Arbor · R35 · FY2021 · HL
Preventing Anthracycline Cardiovascular Toxicity with Statins
$900,665William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2016 · HL
CCR, LGI, Flow Cytometry Core Facility
$900,397Karen Wolcott · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
FUNCTIONAL ANALYSIS OF SOMATIC MUTATIONS IN LUNG CANCER
$900,151Dana-Farber Cancer Institute, Inc. · · FY2012 · Department of Defense
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS
$900,000G. Yancey Gillespie · University Of Alabama At Birmingham · P20 · FY2011 · CA